ALDR - Alder BioPharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5923.13M
Enterprise Value 3723.89M
Trailing P/E N/A
Forward P/E 1-3.41
PEG Ratio (5 yr expected) 1-0.10
Price/Sales (ttm)N/A
Price/Book (mrq)5.86
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-2.14

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-38.21%
Return on Equity (ttm)-99.05%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-161.99M
EBITDA -337.77M
Net Income Avi to Common (ttm)-333.6M
Diluted EPS (ttm)-4.81
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)474.62M
Total Cash Per Share (mrq)5.68
Total Debt (mrq)190.41M
Total Debt/Equity (mrq)73.01
Current Ratio (mrq)8.34
Book Value Per Share (mrq)1.89

Cash Flow Statement

Operating Cash Flow (ttm)-251.33M
Levered Free Cash Flow (ttm)-171.95M

Trading Information

Stock Price History

Beta (3Y Monthly) 3.25
52-Week Change 3-28.26%
S&P500 52-Week Change 34.50%
52 Week High 320.87
52 Week Low 39.44
50-Day Moving Average 312.54
200-Day Moving Average 312.68

Share Statistics

Avg Vol (3 month) 31.09M
Avg Vol (10 day) 31M
Shares Outstanding 583.5M
Float 71.52M
% Held by Insiders 15.20%
% Held by Institutions 1101.40%
Shares Short (Apr 30, 2019) 413.12M
Short Ratio (Apr 30, 2019) 413.31
Short % of Float (Apr 30, 2019) 421.26%
Short % of Shares Outstanding (Apr 30, 2019) 415.72%
Shares Short (prior month Mar 29, 2019) 412.89M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A